Marie Newman 🔔 get alerts
US Congress (House) · disclosed stock trades and performance vs S&P 500 (2019-2026)
35 %
of picks beat the S&P
-22.5 %
median 12m outperf.
51
buys analyzed
CHWY, MET, FDX
top holdings
In short — Marie Newman underperforms the market: of 51 buys, 35% beat the S&P 500 over 12 months (median outperformance -22.5 %).
Marie Newman's disclosed trades
| Disclosed i ▼ | Stock i ↕ | Amount i ↕ | Perf vs S&P (12m) i ↕ |
|---|---|---|---|
| Dec 8, 21 | AMZN | $15k | -34.5 % |
| Dec 8, 21 | HIPO | $1k | -66.8 % |
| Dec 8, 21 | CRM | $15k | -36.0 % |
| Oct 6, 21 | MET | $1k | +17.0 % |
| Oct 6, 21 | PTON | $1k | -74.1 % |
| Oct 6, 21 | R | $15k | +13.3 % |
| Sep 8, 21 | CNA | $1k | +8.9 % |
| Sep 8, 21 | MSFT | $1k | -2.1 % |
| Aug 5, 21 | CCL | $1k | -51.3 % |
| Aug 5, 21 | CHWY | $1k | -41.2 % |
| Aug 5, 21 | F | $1k | +21.6 % |
| Aug 5, 21 | CRM | $15k | -18.9 % |
| Aug 5, 21 | W | $15k | -67.4 % |
| Jun 10, 21 | MSFT | $15k | +5.8 % |
| May 9, 21 | CHWY | $15k | -59.9 % |
| May 9, 21 | KO | $1k | +23.9 % |
| May 9, 21 | FDX | $15k | -28.7 % |
| May 9, 21 | JNJ | $15k | +9.9 % |
| May 9, 21 | MET | $1k | +5.5 % |
| May 9, 21 | NKE | $1k | -17.1 % |
| May 9, 21 | PTON | $1k | -83.4 % |
| May 9, 21 | W | $15k | -79.7 % |
| Apr 15, 21 | CHWY | $1k | -58.8 % |
| Apr 15, 21 | CHWY | $15k | -58.8 % |
| Apr 15, 21 | CHWY | $1k | -58.8 % |
| Apr 15, 21 | CHWY | $1k | -58.8 % |
| Apr 15, 21 | EA | $1k | -18.9 % |
| Apr 15, 21 | FDX | $15k | -33.9 % |
| Apr 15, 21 | KR | $1k | +53.9 % |
| Apr 15, 21 | MET | $1k | +9.1 % |
| Apr 15, 21 | NKE | $1k | -6.2 % |
| Apr 15, 21 | PTON | $1k | -85.8 % |
| Apr 15, 21 | PTON | $1k | -85.8 % |
| Apr 15, 21 | PFE | $1k | +36.3 % |
| Apr 15, 21 | R | $1k | -21.6 % |
| Apr 15, 21 | VRM | $1k | -48.5 % |
| Apr 15, 21 | VRM | $1k | -48.5 % |
| Apr 15, 21 | CHWY | $1k | -58.8 % |
| Apr 15, 21 | EA | $1k | -18.9 % |
| Apr 15, 21 | FDX | $15k | -33.9 % |
| Apr 15, 21 | FDX | $15k | -33.9 % |
| Apr 15, 21 | WMT | $1k | +7.2 % |
| Feb 13, 21 | XOM | $1k | +40.5 % |
| Feb 13, 21 | XOM | $1k | +40.5 % |
| Feb 13, 21 | MCD | $15k | +6.4 % |
| Feb 13, 21 | MCD | $15k | +6.4 % |
| Feb 13, 21 | MET | $1k | +17.8 % |
| Feb 13, 21 | MSFT | $15k | +8.6 % |
| Feb 13, 21 | MRNA | $1k | -29.7 % |
| Feb 13, 21 | WMT | $1k | -22.5 % |
| Feb 13, 21 | W | $15k | -60.9 % |
⚠️ 51 buys with 12 months of hindsight. Perf vs S&P 500 measured from the disclosure date. Public data (House PTRs), transparency — not advice nor a guarantee.
🔔 Get notified of Marie Newman's next trades
Free, unsubscribe anytime. Transparency data, not advice.
Frequently asked questions
Does Marie Newman beat the market?
Across 51 disclosed buys (2019-2026) measured from their disclosure date, 35% beat the S&P 500 over 12 months, with a median outperformance of -22.5 %. In other words, Marie Newman underperforms the market.
Which stocks does Marie Newman buy?
Most-bought tickers: CHWY, MET, FDX, PTON, MSFT, W. Full detail (dates, amounts, performance) is in the table above.
Is this data reliable?
It comes from official House Periodic Transaction Reports (PTRs), mandatory under the STOCK Act. It's transparency, not advice: past performance doesn't predict the future, and a small number of trades stays statistically weak.